These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8814365)

  • 1. Collagen-binding activity of plasma vitronectin in chronic liver disease.
    Yamada S; Kobayashi J; Murawaki Y; Suou T; Kawasaki H
    Clin Chim Acta; 1996 Aug; 252(1):95-103. PubMed ID: 8814365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma collagen-binding vitronectin activated by heparin and dextran sulfate in chronic liver disease.
    Yamada S; Kobayashi J; Kawasaki H
    Res Commun Mol Pathol Pharmacol; 1997 Sep; 97(3):315-24. PubMed ID: 9387191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum 7S collagen in various liver diseases.
    Yamada S; Suou T; Kawasaki H; Yoshikawa N
    Clin Biochem; 1992 Dec; 25(6):467-70. PubMed ID: 1335851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
    Tomihira M
    Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration of serum laminin and type IV collagen in liver diseases assayed by a sandwich enzyme-immunoassay using monoclonal antibodies.
    Yokoya Y; Iwata K; Muragaki Y; Shiota C; Morimoto Y; Inoue M; Itoh H; Nishioka S; Ooshima A
    Clin Chim Acta; 1992 Sep; 210(1-2):109-18. PubMed ID: 1330375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum 7S collagen and type VI collagen levels for the diagnosis of hepatic fibrosis.
    Ji X; Li S; Kong X; Xu G; Chen J; Dai X
    Chin Med J (Engl); 1997 Mar; 110(3):198-201. PubMed ID: 9594340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma.
    Murawaki Y; Yamamoto H; Kawasaki H; Shima H
    Clin Chim Acta; 1993 Sep; 218(1):47-58. PubMed ID: 8299219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum collagenase activity in patients with chronic liver disease.
    Murawaki Y; Koda M; Yamada S; Kawasaki H; Shima H; Burkhardt H
    J Hepatol; 1993 Jul; 18(3):328-34. PubMed ID: 8228126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma prekallikrein in chronic liver diseases].
    Ciechanowicz A; Miks B; Kawiak J; Ciechanowski K; Ryszkiewicz D; Długosz A; Syczewska-Wawrzynowicz M; Marzecka J; Czekalski S
    Pol Arch Med Wewn; 1995 Nov; 94(5):395-401. PubMed ID: 8833936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease.
    Murawaki Y; Ikuta Y; Koda M; Yamada S; Kawasaki H
    J Hepatol; 1996 Feb; 24(2):148-54. PubMed ID: 8907567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of serum cystatin C concentrations in patients with chronic liver disease.
    Takeuchi M; Fukuda Y; Nakano I; Katano Y; Hayakawa T
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):951-5. PubMed ID: 11507361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of vitronectin in plasma and liver tissue: relationship to chronic liver disease.
    Kobayashi J; Yamada S; Kawasaki H
    Hepatology; 1994 Dec; 20(6):1412-7. PubMed ID: 7527001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of marker for hepatic fibrosis and viral status on recurrence after resection of hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Tsukamoto T; Kawai S; Hirohashi K; Tanaka H; Shuto T; Takemura S; Nishiguchi S; Kinoshita H
    Hepatogastroenterology; 2003; 50(50):497-9. PubMed ID: 12749255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor necrosis factor alpha levels in patients with chronic liver diseases and its relationship to pathogenesis].
    Yuan AL; Luo YH; Liu SD
    Zhonghua Nei Ke Za Zhi; 1994 Oct; 33(10):672-4. PubMed ID: 7712914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of plasma thrombomodulin (TM) levels in patients with liver disease].
    Akiyama K; Nakamura K; Makino I
    Nihon Shokakibyo Gakkai Zasshi; 1992 Oct; 89(10):2559-67. PubMed ID: 1328724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tenascin levels in chronic liver disease.
    Yamauchi M; Mizuhara Y; Maezawa Y; Toda G
    Liver; 1994 Jun; 14(3):148-53. PubMed ID: 7521506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic roles of serum vitronectin in hepatitis B-related hepatocellular carcinoma.
    Yang XP; Zhou LX; Yang QJ; Liu L; Cai Y; Ma SL
    Cancer Biomark; 2016 Sep; 17(3):271-279. PubMed ID: 27802203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.
    Kawasaki H; Uemasu J; Maeda N; Hirayama C; Kobayashi T; Sakurai H
    Am J Gastroenterol; 1987 Aug; 82(8):727-31. PubMed ID: 3037881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.